Metastatic Breast Cancer Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Metastatic Breast Cancer

09 Dec 2021
Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar

By PBR Staff Writer

Prestige BioPharma and Dr. Reddy’s Laboratories have signed a binding agreement to commercialise the former’s trastuzumab (HD201) biosimilar in select Latin America and Southeast Asian countries.
24 Nov 2021
Metastatic Breast Cancer
Gilead’s Trodelvy secures EC approval for Metastatic TNBC treatment

By PBR Staff Writer

Gilead Sciences has received marketing authorisation from the European Commission (EC) for Trodelvy (sacituzumab govitecan) to treat adult patients suffering from unresectable or metastatic triple-negative breast cancer (TNBC).